Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022.The global digital pathology market size will reach $756.1 million by 2022 from $423.1 million in 2017 at a CAGR of 12.3% during (2017-2022) driven by rising prevalence of cancer, increasing adoption of digital pathology to enhance lab efficiency, increasing initiatives by governments & industry players, ease of consultation, and growing applications of digital pathology in drug development and companion diagnostics. North America to dominate the digital pathology market and APAC projected to grow at the highest CAGR during the forecast period.
Download PDF Brochure of 85 Digital Pathology Market spread across Market Data Tables and 33 Figures spread through 154 Pages and in-depth TOC is now available at www.reportsnreports.com/contacts/r….aspx?name=195916 .
The North America is expected to hold the largest share of the global digital pathology market in 2017.
The large share of this region can be attributed to factors such as the rising prevalence of chronic diseases and increasing initiatives by industry players and governments in diagnostics. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.
Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.
The major players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), and Hamamatsu Photonics (Japan). Other players include 3DHISTECH (Hungary), Philips (Netherlands), Apollo Enterprise Imaging (US), XIFIN (US), Visiopharm (Denmark), Corista (US), Huron Digital Pathology (Canada), Objective Pathology Services (Canada), and Indica Labs (US).
Make an Inquiry on “Digital Pathology Market - Global Forecast to 2022” research report at www.reportsnreports.com/contacts/i….aspx?name=195916 .
On the basis of end user, the digital pathology market is classified into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the digital pathology market.
Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for bio banking, biopharmaceutical studies, and molecular assays.
The software segment account largest share of the digital pathology market. By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems.
The scanners segment is estimated to account for the largest share of the global digital pathology market in 2017. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe.
Inquire for “Digital Pathology Market - Global Forecast to 2022” research report at www.reportsnreports.com/contacts/d….aspx?name=195916 .
The report analyzes the digital pathology market and aims at estimating the market size and the future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Break of primary participants was as mentioned below:
- By Company Type: Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
- By Designation: C-level: 27%, Director Level: 15%, Others: 58%
- By Region: North America: 45%, Europe: 29%, Asia-Pacific: 20%, RoW: 6%